Skip to main content
SpringerLink
Log in

Update in Addiction Medicine for the Generalist

  • Review
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41(10):949–58.

    CAS  PubMed  Google Scholar 

  2. Institute of Medicine. Improving the quality of healthcare for mental and substance-use conditions: The quality chasm series. Washington, DC: The National Academies Press; 2005.

    Google Scholar 

  3. Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: The National Academies Press; 2001.

    Google Scholar 

  4. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.

    Article  PubMed  Google Scholar 

  5. Gordon AJ, Sullivan LE, Alford DP, et al. Update in addiction medicine for the generalist. J Gen Intern Med. 2007;22(8):1190–4.

    Article  PubMed  Google Scholar 

  6. Gordon AJ, Fiellin DA, Friedmann PD, et al. Update in addiction medicine for the primary care clinician. J Gen Intern Med. 2008;23(12):2112–6.

    Article  PubMed  Google Scholar 

  7. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85–92.

    PubMed  Google Scholar 

  8. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–20.

    Article  CAS  PubMed  Google Scholar 

  9. Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction. 2009;104(6):993–9.

    Article  PubMed  Google Scholar 

  10. Paulozzi LJ, Logan JE, Hall AJ, McKinstry E, Kaplan JA, Crosby AE. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction. 2009;104(9):1541–8.

    Article  PubMed  Google Scholar 

  11. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc Interval Screening in Methadone Treatment: the CSAT Consensus Guideline. Ann Intern Med. 2008.

  12. Gourevitch MN. First do no harm…Reduction? Ann Intern Med. 2009;150(6):417–8.

    PubMed  Google Scholar 

  13. McLellan AT, Turner BJ. Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann Intern Med. 2010;152(2):123–4.

    PubMed  Google Scholar 

  14. Solberg LI, Maciosek MV, Edwards NM. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness. Am J Prev Med. 2008;34(2):143–52.

    Article  PubMed  Google Scholar 

  15. D'Amico EJ, Paddock SM, Burnam A, Kung FY. Identification of and guidance for problem drinking by general medical providers: results from a national survey. Med Care. 2005;43(3):229–36.

    Article  PubMed  Google Scholar 

  16. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24(7):783–8.

    Article  PubMed  Google Scholar 

  17. Friedmann PD, McCullough D, Chin MH, Saitz R. Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med. 2000;15(2):84–91.

    Article  CAS  PubMed  Google Scholar 

  18. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction. 1993;88(6):791–804.

    Article  CAS  PubMed  Google Scholar 

  19. Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcoholism: Clinical & Experimental Research. 1997;21(4):613–9.

    CAS  Google Scholar 

  20. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183-94.

    Google Scholar 

  21. Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions to identify alcohol use disorders. Alcohol Clin Exp Res. 2007;31(8):1392–8.

    Article  PubMed  Google Scholar 

  22. Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res. 2005;29(5):844–54.

    Article  PubMed  Google Scholar 

  23. Gordon AJ, Maisto SA, McNeil M, et al. Three questions can detect hazardous drinkers. J Fam Pract. 2001;50(4):313–20.

    CAS  PubMed  Google Scholar 

  24. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Arch Intern Med. 1998;158(16):1789–95.

    Article  CAS  PubMed  Google Scholar 

  25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  26. Cervantes EA, Miller WR, Tonigan JS. Comparison of Timeline Follow-Back and Averaging Methods for Quantifying Alcohol Consumption in Treatment Research. Assessment. 1994;1(1):23–30.

    Article  PubMed  Google Scholar 

  27. Maisto SA, Conigliaro JC, Gordon AJ, Mcginnis KA, Justice AC. An experimental study of the agreement of self-administration and telephone administration of the Timeline Followback interview. J Stud Alcohol Drugs. 2008;69(3):468–71.

    PubMed  Google Scholar 

  28. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1–3):280–95.

    Article  PubMed  Google Scholar 

  29. Krupski A, Sears JM, Joesch JM et al. Impact of brief interventions and brief treatment on admissions to chemical dependency treatment. Drug Alcohol Depend. 2010.

  30. Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7–30.

    Article  PubMed  Google Scholar 

  31. The impact of screening, brief intervention, and referral for treatment on emergency department patients' alcohol use. Ann Emerg Med. 2007;50(6):699-710, 710.

    Google Scholar 

  32. Fleming MF, Barry KL, Manwell LB, Johnson K, London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA. 1997;277(13):1039–45.

    Article  CAS  PubMed  Google Scholar 

  33. Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res. 2002;26(1):36–43.

    PubMed  Google Scholar 

  34. Otto C, Crackau B, Lohrmann I, et al. Brief intervention in general hospital for problematic prescription drug use: 12-month outcome. Drug Alcohol Depend. 2009;105(3):221–6.

    Article  PubMed  Google Scholar 

  35. Zahradnik A, Otto C, Crackau B, et al. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction. 2009;104(1):109–17.

    Article  PubMed  Google Scholar 

  36. McQueen J, Howe TE, Allan L, Mains D. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2009;(3):CD005191.

  37. Guth S, Lindberg SA, Badger GJ, Thomas CS, Rose GL, Helzer JE. Brief intervention in alcohol-dependent versus nondependent individuals. J Stud Alcohol Drugs. 2008;69(2):243–50.

    PubMed  Google Scholar 

  38. Stewart SH, Latham PK, Miller PM, Randall P, Anton RF. Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. Addiction. 2008;103(10):1622–8.

    Article  PubMed  Google Scholar 

  39. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003–17.

    Article  CAS  PubMed  Google Scholar 

  40. Nordback I, Pelli H, Lappalainen-Lehto R, Jarvinen S, Raty S, Sand J. The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial. Gastroenterology. 2009;136(3):848–55.

    Article  PubMed  Google Scholar 

  41. Gunnell D, Irvine D, Wise L, Davies C, Martin RM. Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ. 2009;339:b3805.

    Article  CAS  PubMed  Google Scholar 

  42. Quinn VP, Hollis JF, Smith KS, et al. Effectiveness of the 5-As tobacco cessation treatments in nine HMOs. J Gen Intern Med. 2009;24(2):149–54.

    Article  PubMed  Google Scholar 

  43. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008;(3):CD006103.

  44. Kuehn BM. Studies linking smoking-cessation drug with suicide risk spark concerns. JAMA. 2009;301(10):1007–8.

    Article  CAS  PubMed  Google Scholar 

  45. Kasliwal R, Wilton LV, Shakir SA. Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study. Drug Saf. 2009;32(6):499–507.

    Article  CAS  PubMed  Google Scholar 

  46. Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med. 2008;23(9):1393–8.

    Article  PubMed  Google Scholar 

  47. Drug Addiction Treatment Act of 2000, 42 USC§3502a, Drug Addiction Treatment Act of 2000, (2000)

  48. Barry DT, Irwin KS, Jones ES et al. Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study. J Gen Intern Med. 2008.

  49. Soeffing JM, Martin LD, Fingerhood MI, Jasinski DR, Rastegar DA. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year. J Subst Abuse Treat. 2009;37(4):426–30.

    Article  PubMed  Google Scholar 

  50. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2004;(3):CD002207.

  51. Fiellin DA, Moore BA, Sullivan LE, et al. Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict. 2008;17(2):116–20.

    Article  PubMed  Google Scholar 

  52. Parran TV, Adelman CA, Merkin B, et al. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy. Drug Alcohol Depend. 2010;106(1):56–60.

    Article  CAS  PubMed  Google Scholar 

  53. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349(10):949–58.

    Article  CAS  PubMed  Google Scholar 

  54. Gordon AJ, Trafton JA, Saxon AJ, et al. Implementation of buprenorphine in the Veterans Health Administration: Results of the first 3 years. Drug Alcohol Depend. 2007;90:292–6.

    Article  CAS  PubMed  Google Scholar 

  55. Gordon AJ, Liberto J, Granda S, Salmon-Cox S, Andree T, McNicholas L. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration. Am J Addict. 2008;17(6):459–62.

    Article  PubMed  Google Scholar 

  56. Miller NS, Sheppard LM, Colenda CC, Magen J. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med. 2001;76(5):410–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the editorial assistance of Margaret Krumm in preparation of this manuscript. No financial support was received by the authors for the work represented in this manuscript. This work was presented in an invited oral presentation at the 2010 Annual meeting of the Society of General Internal Medicine. Minneapolis, Minneapolis, May 1, 2010.

Conflict of Interest

None disclosed

Author information

Authors and Affiliations

  1. Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, 7180 Highland Drive (151-C-H), Pittsburgh, PA, 15206, USA

    Adam J. Gordon MD, MPH

  2. Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY, USA

    Hillary V. Kunins MD, MPH, MS

  3. Johns Hopkins School of Medicine, Baltimore, MD, USA

    Darius A. Rastegar MD

  4. Yale University School of Medicine, New Haven, CT, USA

    Jeanette M. Tetrault MD

  5. Boston University School of Medicine, Boston, MA, USA

    Alexander Y. Walley MD, MSc

Authors
  1. Adam J. Gordon MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hillary V. Kunins MD, MPH, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Darius A. Rastegar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeanette M. Tetrault MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexander Y. Walley MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam J. Gordon MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, A.J., Kunins, H.V., Rastegar, D.A. et al. Update in Addiction Medicine for the Generalist. J GEN INTERN MED 26, 77–82 (2011). https://doi.org/10.1007/s11606-010-1461-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-010-1461-3

Key words

Search

Navigation